These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 9043916

  • 1. Effect of low daily doses of mifepristone on ovarian function and endometrial development.
    Danielsson KG, Swahn ML, Westlund P, Johannisson E, Seppälä M, Bygdeman M.
    Hum Reprod; 1997 Jan; 12(1):124-31. PubMed ID: 9043916
    [Abstract] [Full Text] [Related]

  • 2. Effect of low weekly doses of mifepristone on ovarian function and endometrial development.
    Gemzell-Danielsson K, Westlund P, Johannisson E, Swahn ML, Bygdeman M, Seppälä M.
    Hum Reprod; 1996 Feb; 11(2):256-64. PubMed ID: 8671205
    [Abstract] [Full Text] [Related]

  • 3. Effect of two antiprogestins (mifepristone and onapristone) on endometrial factors of potential importance for implantation.
    Cameron ST, Critchley HO, Buckley CH, Kelly RW, Baird DT.
    Fertil Steril; 1997 Jun; 67(6):1046-53. PubMed ID: 9176442
    [Abstract] [Full Text] [Related]

  • 4. Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy.
    Batista MC, Cartledge TP, Zellmer AW, Merino MJ, Axiotis C, Loriaux DL, Nieman LK.
    Am J Obstet Gynecol; 1992 Jul; 167(1):60-5. PubMed ID: 1442957
    [Abstract] [Full Text] [Related]

  • 5. Effects of a sequential regimen of mifepristone-medroxyprogesterone acetate on ovarian function, endometrial development and hormonal parameters.
    Croxatto HB, Massai MR, Salvatierra AM, Fuentealba B, Croxatto HD, Lähteenmäki P.
    Contraception; 1996 Aug; 54(2):79-86. PubMed ID: 8842583
    [Abstract] [Full Text] [Related]

  • 6. Effects of a single post-ovulatory dose of RU486 on endometrial maturation in the implantation phase.
    Gemzell-Danielsson K, Svalander P, Swahn ML, Johannisson E, Bygdeman M.
    Hum Reprod; 1994 Dec; 9(12):2398-404. PubMed ID: 7714164
    [Abstract] [Full Text] [Related]

  • 7. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
    Swahn ML, Johannisson E, Daniore V, de la Torre B, Bygdeman M.
    Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of ovulation by low-dose mifepristone (RU 486).
    Ledger WL, Sweeting VM, Hillier H, Baird DT.
    Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
    [Abstract] [Full Text] [Related]

  • 9. Effect of daily low dose mifepristone on the ovarian cycle and on dynamics of follicle growth.
    Cameron ST, Thong KJ, Baird DT.
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):407-14. PubMed ID: 7586613
    [Abstract] [Full Text] [Related]

  • 10. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.
    Greene KE, Kettel LM, Yen SS.
    Fertil Steril; 1992 Aug; 58(2):338-43. PubMed ID: 1633899
    [Abstract] [Full Text] [Related]

  • 11. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
    Katkam RR, Gopalkrishnan K, Chwalisz K, Schillinger E, Puri CP.
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):779-87. PubMed ID: 7573244
    [Abstract] [Full Text] [Related]

  • 12. Effects of long-term low-dose mifepristone on reproductive function in women.
    Croxatto HB, Kovács L, Massai R, Resch BA, Fuentealba B, Salvatierra AM, Croxatto HD, Zalányi S, Viski S, Krenács L.
    Hum Reprod; 1998 Apr; 13(4):793-8. PubMed ID: 9619526
    [Abstract] [Full Text] [Related]

  • 13. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation.
    Gemzell-Danielsson K, Swahn ML, Svalander P, Bygdeman M.
    Hum Reprod; 1993 Jun; 8(6):870-3. PubMed ID: 8345076
    [Abstract] [Full Text] [Related]

  • 14. The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium.
    Swahn ML, Bygdeman M, Cekan S, Xing S, Masironi B, Johannisson E.
    Hum Reprod; 1990 May; 5(4):402-8. PubMed ID: 2113927
    [Abstract] [Full Text] [Related]

  • 15. Effect of tamoxifen alone and in combination with RU 486 on the endometrium in the mid-luteal phase.
    Swahn ML, Bygdeman M, Seppälä M, Johannisson E, Cekan S.
    Hum Reprod; 1993 Feb; 8(2):193-200. PubMed ID: 8473418
    [Abstract] [Full Text] [Related]

  • 16. The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function.
    Collins WP, Collins PO, Kilpatrick MJ, Manning PA, Pike JM, Tyler JP.
    Acta Endocrinol (Copenh); 1979 Feb; 90(2):336-48. PubMed ID: 419920
    [Abstract] [Full Text] [Related]

  • 17. Mode of action of RU 486.
    Bygdeman M, Swahn ML, Gemzell-Danielsson K, Svalander P.
    Ann Med; 1993 Feb; 25(1):61-4. PubMed ID: 8435191
    [Abstract] [Full Text] [Related]

  • 18. Sonographic assessment of ovarian and endometrial changes during long-term Norplant use and their correlation with hormonal levels.
    Shaaban MM, Segal S, Salem HT, Ghaneimah SA, Khalifa EA, Ahmed AG.
    Fertil Steril; 1993 May; 59(5):998-1002. PubMed ID: 8486202
    [Abstract] [Full Text] [Related]

  • 19. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB, Salvatierra AM, Romero C, Spitz IM.
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [Abstract] [Full Text] [Related]

  • 20. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
    Kekkonen R, Alfthan H, Haukkamaa M, Heikinheimo O, Luukkainen T, Lähteenmäki P.
    Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.